Investment in decentralized clinical trials pays off: analysis
A joint study conducted by analysts from Medable and the Center for the Study of Drug Development points toward shorter cycle times, cost savings, and more.
Archives for July 28, 2022
Incorporating patient voice elevates rare-disease trials: Casimir
During the World Orphan Drug Congress, a co-founder of the CRO outlined how patient perspective can be vital to better results in rare-disease research.